Chemistry:Tersolisib
From HandWiki
Tersolisib is an investigational new drug that is being evaluated by Eli Lilly and Company for the treatment of solid tumors. It is a PI3Kα inhibitor.[1][2]
References
- ↑ "Tersolisib - Eli Lilly and Company". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800066441.
- ↑ "The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies". Biomedicines 13 (6): 1319. May 2025. doi:10.3390/biomedicines13061319. PMID 40564038.
